Results 131 to 140 of about 87,208 (292)

Diagnostic and Therapeutic Impact of FDG‐PET/CT Following MRI Staging in Anal Cancer: A Systematic Review and Meta‐Analysis

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Accurate staging is essential in anal cancer to guide therapy and prognostication. While MRI remains the modality of choice for local staging, its limitations in assessing nodal and distant metastases have prompted evaluation of FDG PET/CT as an adjunct.
Hugo C. Temperley   +12 more
wiley   +1 more source

Individualized T3‐4N+ Rectal Cancer Treatment Strategies: Exploring the Efficacy of Preoperative Synchronized Lateral Lymph Node Simultaneous Integrated Boost Radiation Therapy

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Anatomical Diagram: It shows a cross‐section of the pelvic area highlighting the rectum and lateral lymph nodes, which are the focal points of the treatment strategy discussed in the paper. Flowchart: It outlines the treatment process from preoperative synchronized radiation therapy to the subsequent surgical procedures, illustrating the sequence of ...
Xinjue Shi   +7 more
wiley   +1 more source

Understanding and Addressing Clinical Variation in Rectal Cancer Care: Application of an Analytic Framework

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
There is substantial clinical variation in the use of neoadjuvant radiotherapy for high‐risk rectal cancer, ranging from 25% to 59% in New South Wales, Australia. Assessed against an empirically based analytic framework, the reasons for this clinical variation were largely unwarranted and related to MDT processes, imaging quality, workforce/practice ...
Bernadette (Bea) Brown   +4 more
wiley   +1 more source

Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes. [PDF]

open access: yesJ Clin Med
Yildirim S   +10 more
europepmc   +1 more source

Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy

open access: green, 2017
Seung Yeun Chung   +5 more
openalex   +2 more sources

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown   +7 more
wiley   +1 more source

A Phase 2 Trial of Surgery With Perioperative INGN 201 (Ad5CMV-p53) Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, and Larynx

open access: green, 2009
George H. Yoo   +10 more
openalex   +2 more sources

Microbiota in cancer chemoradiotherapy resistance [PDF]

open access: yesClinical and Translational Medicine, 2020
He, Yan   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy